Use access key #2 to skip to page content.
$17.82 -1.12 (-5.90%)
10/7/2008 4:02 PM

Pfizer, Inc. (PFE)

CAPS Rating:
****

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

View Ticker Page (PFE)

Results 31 - 40 of 784 :   12345Next »

Recs

2

Avatar rtmorse (< 20) Submitted: 10/03/06 2:57 PM : Outperform Start Price: $25.82 PFE Score: -6.25

as the current economy slows and the fed gears us up for a so called soft landing, watch for a continued surge in consumer staples and big pharma stocks, especially ones undervalued as much as PFE

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar ax2y1 (54.78) Submitted: 2/22/07 4:02 PM : Outperform Start Price: $24.82 PFE Score: 1.81

I am always wary of people who discount companies with really good histories. There are reasons for the "good" part which seem to be part of each company no matter who leads it. Remember MMM when what's his name came over from GE. The company did ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar empirefool (98.56) Submitted: 6/28/06 12:18 AM : Outperform Start Price: $20.93 PFE Score: 4.65

Drugs are out of favor, shareholder friendly management and 4.2% dividend.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar robert1schreiber (20.31) Submitted: 3/27/07 9:31 AM : Underperform Start Price: $23.68 PFE Score: -5.40

This organization pulled a potentialially valuable drug from the pipeline and has hurt their earnings potential. Furthermore, the money paid to the past President of Pfizer has caused a lot of folks to lose faith in the organization.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar JBouchard (99.31) Submitted: 12/07/06 2:36 PM : Outperform Start Price: $22.70 PFE Score: 7.96

As a good play on the aging population in North America, the company seems well-positioned.

I've been following the company for a couple of months, and the bad news wih the failure of torcetrapib (which comes on top of a recent slump on the share pr...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar rlipsitz (54.77) Submitted: 4/11/07 10:59 AM : Outperform Start Price: $23.82 PFE Score: 5.33

Huge company down now but will continue R&R, in meantime while waiting fro new great products you get an excellent dividend. Stock undervalued now and could rebound anytime. INvest now wait for price to come near valuation levels and in meantime earn...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar danblanchard (< 20) Submitted: 1/08/08 9:52 PM : Outperform Start Price: $25.78 PFE Score: -5.85

They're going to buy someone soon. They can't keep growing buy laying off their sales force. Their pipeline is hurting for certain. Nothing going on that's too promising in Stage 3 trials. Look for a buy in the pain management sector.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar prvtinv (45.43) Submitted: 9/26/06 1:00 AM : Outperform Start Price: $25.82 PFE Score: -6.90

A blue chip in the pharma... market.
currently a out of favor sector with wallstreet where the moto is...what have you done for me lately
and the money bets are placed elsewhere.

Long term with our population getting gray'er Pfizer has the drugs ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar RVAspeculator (< 20) Submitted: 7/22/08 11:02 PM : Outperform Start Price: $17.56 PFE Score: 27.71

In the 17's with a 7+% dividend. I want to own this no matter what is going on in the market. Boring outperformer in my opinion.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar gainloss (62.63) Submitted: 12/04/06 10:36 AM : Outperform Start Price: $22.22 PFE Score: 9.12

Stock is worth $25 at 0% growth using cash flow as a metric. With an aging population to think that profits will not grow is quite bearish. After the 13% haircut today, PFE looks like a nice, fairly risky 2-5 year play to get you a 15-25% return.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners